Periodontitis and metabolic diseases (diabetes and obesity): Tackling multimorbidity.
diabetes
lifestyles
morbidities
obesity
periodontal diseases
Journal
Periodontology 2000
ISSN: 1600-0757
Titre abrégé: Periodontol 2000
Pays: Denmark
ID NLM: 9313276
Informations de publication
Date de publication:
16 Oct 2023
16 Oct 2023
Historique:
revised:
21
09
2023
received:
27
07
2023
accepted:
23
09
2023
medline:
17
10
2023
pubmed:
17
10
2023
entrez:
17
10
2023
Statut:
aheadofprint
Résumé
Noncommunicable diseases (NCDs) are multifactorial, long-term, chronic conditions that represent a burden to health-care systems worldwide as they can only be controlled rather than cured; hence, they require long-term care. With the exponential increase in NCDs, the occurrence of individuals presenting with more than one chronic disease is also rapidly rising. "Multimorbidity," defined as the presence of two or more long-term physical or mental disorders, is now considered a worldwide epidemic, affecting around 20% of the adult population. Periodontitis, diabetes, and obesity, all chronic inflammatory diseases, are an example of multimorbidity highly relevant to dental practitioners. Over the last three decades, the three-way relationship among the diseases has been vastly researched and accepted, with important contributions by European researchers. The interplay among periodontitis, diabetes, and obesity is sustained by shared biological mechanisms, such as systemic inflammation, insulin resistance, and metabolic dysfunction, as well as common lifestyle-related risk factors. As such, unhealthy lifestyles were found to generally increase systemic inflammation and insulin resistance and decrease immune function, hence, eventually increasing the risk of NCDs onset and the development of multimorbidity. This narrative review of the evidence supports the need for a paradigm shift from a "single-disease" to a "multiple-disease" framework, characterized by an integrated multidisciplinary approach, which should include lifestyle modification interventions to successfully tackle multimorbid periodontitis and metabolic diseases (diabetes and obesity). A multidisciplinary integrated care pathway in both dental and medical settings should be considered to further tackle the global health challenge of multimorbidity.
Types de publication
Journal Article
Review
Langues
eng
Informations de copyright
© 2023 The Authors. Periodontology 2000 published by John Wiley & Sons Ltd.
Références
World Health Organization. Non Communicable Diseases. 2022. Accessed June 26, 2023. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
Marrero SL, Bloom DE, Adashi EY. Noncommunicable Diseases A Global Health Crisis in a New World Order. 2012 http://www.un.org/en/ga/ncdmeeting2011/
Kassebaum NJ, Bernabé E, Dahiya M, Bhandari B, Murray CJL, Marcenes W. Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J Dent Res. 2014;93(11):1045-1053. doi:10.1177/0022034514552491
Ong KL, Stafford LK, McLaughlin SA, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402:203-234. doi:10.1016/S0140-6736(23)01301-6
Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766-781. doi:10.1016/S0140-6736(14)60460-8
Guthrie B, Barnett K, Mercer SW, Norbury M, Watt G, Wyke S. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37-43. doi:10.1016/S0140-6736(12)60240-2
Sayburn A. Lifestyle medicine: a new medical specialty? BMJ (Online). 2018;363:k4442. doi:10.1136/bmj.k4442
Yang L, Cao C, Kantor ED, et al. Trends in sedentary behavior among the US population, 2001-2016. JAMA. 2019;321(16):1587-1597. doi:10.1001/jama.2019.3636
Mireku MO, Barker MM, Mutz J, et al. Night-time screen-based media device use and adolescents' sleep and health-related quality of life. Environ Int. 2019;124:66-78. doi:10.1016/j.envint.2018.11.069
Harb AA, Shechter A, Koch PA, St-Onge MP. Ultra-processed foods and the development of obesity in adults. Eur J Clin Nutr. 2022;77:619-627. doi:10.1038/s41430-022-01225-z
Stöhr J, Barbaresko J, Neuenschwander M, Schlesinger S. Bidirectional association between periodontal disease and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Sci Rep. 2021;11(1):13686. doi:10.1038/s41598-021-93062-6
Sanz M, Herrera D, Kebschull M, et al. Treatment of stage I-III periodontitis-the EFP S3 level clinical practice guideline. J Clin Periodontol. 2020;47(S22):4-60. doi:10.1111/jcpe.13290
Orlandi M, Muñoz Aguilera E, Marletta D, Petrie A, Suvan J, D'Aiuto F. Impact of the treatment of periodontitis on systemic health and quality of life: a systematic review. J Clin Periodontol. 2022;49(S24):314-327. doi:10.1111/jcpe.13554
Simpson TC, Clarkson JE, Worthington HV, et al. Treatment of periodontitis for glycaemic control in people with diabetes mellitus. Cochrane Database Syst Rev. 2022;2022(4):CD004714. doi:10.1002/14651858.CD004714.pub4
Oliveira VB, Costa FWG, Haas AN, Júnior RMM, Rêgo RO. Effect of subgingival periodontal therapy on glycaemic control in type 2 diabetes patients: meta-analysis and meta-regression of 6-month follow-up randomized clinical trials. J Clin Periodontol. 2023;50:1123-1137. doi:10.1111/jcpe.13830
D'Aiuto F, Gkranias N, Bhowruth D, et al. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-Centre, investigator-masked, randomised trial. Lancet Diabetes Endocrinol. 2018;6(12):954-965. doi:10.1016/S2213-8587(18)30038-X
Wang Y, Liu HN, Zhen Z, et al. A randomized controlled trial of the effects of non-surgical periodontal therapy on cardiac function assessed by echocardiography in type 2 diabetic patients. J Clin Periodontol. 2020;47(6):726-736. doi:10.1111/jcpe.13291
Engebretson SP, Hyman LG, Michalowicz BS, et al. The effect of nonsurgical periodontal therapy on hemoglobin a1c levels in persons with type 2 diabetes and chronic periodontitis a randomized clinical trial. JAMA. 2013;310(23):2523-2532. doi:10.1001/jama.2013.282431
Ramseier CA, Suvan JE. Behaviour change counselling for tobacco use cessation and promotion of healthy lifestyles: a systematic review. J Clin Periodontol. 2015;42:S47-S58. doi:10.1111/jcpe.12351
De Araújo AA, Pereira ADSBF, De Medeiros CACX, et al. Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis. PloS One. 2017;12(8):e0183506. doi:10.1371/journal.pone.0183506
Kurian IG, Dileep P, Ipshita S, Pradeep AR. Comparative evaluation of subgingivally-delivered 1% metformin and Aloe vera gel in the treatment of intrabony defects in chronic periodontitis patients: a randomized, controlled clinical trial. J Investig Clin Dent. 2018;9(3):e12324. doi:10.1111/jicd.12324
Pankaj D, Sahu I, Kurian IG, Pradeep AR. Comparative evaluation of subgingivally delivered 1.2% rosuvastatin and 1% metformin gel in treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical trial. J Periodontol. 2018;89(11):1318-1325. doi:10.1002/JPER.17-0434
Jepsen S, Suvan J, Deschner J. The association of periodontal diseases with metabolic syndrome and obesity. Periodontol 2000. 2020;83(1):125-153. doi:10.1111/prd.12326
Suvan JE, Finer N, D'Aiuto F. Periodontal complications with obesity. Periodontol 2000. 2018;78(1):98-128. doi:10.1111/prd.12239
Suvan JE, Petrie A, Nibali L, et al. Association between overweight/obesity and increased risk of periodontitis. J Clin Periodontol. 2015;42(8):733-739. doi:10.1111/jcpe.12421
Suvan J, D'Aiuto F, Moles DR, Petrie A, Donos N. Association between overweight/obesity and periodontitis in adults. A systematic review. Obes Rev. 2011;12(5):e381-e404. doi:10.1111/j.1467-789X.2010.00808.x
Martens L, De Smet S, Yusof MYPM, Rajasekharan S. Association between overweight/obesity and periodontal disease in children and adolescents: a systematic review and meta-analysis. Eur Arch Paediatr Dent. 2017;18(2):69-82. doi:10.1007/s40368-017-0272-1
Keller A, Rohde JF, Raymond K, Heitmann BL. Association between periodontal disease and overweight and obesity: a systematic review. J Periodontol. 2015;86(6):766-776. doi:10.1902/jop.2015.140589
Suvan J, Petrie A, Moles DR, et al. Body mass index as a predictive factor of periodontal therapy outcomes. J Dent Res. 2014;93(1):49-54. doi:10.1177/0022034513511084
Suvan J, Harrington Z, Petrie A, et al. Obesity as predictive factor of periodontal therapy clinical outcomes: a cohort study. J Clin Periodontol. 2020;47(5):594-601. doi:10.1111/jcpe.13261
Morita I, Okamoto Y, Yoshii S, et al. Five-year incidence of periodontal disease is related to body mass index. J Dent Res. 2011;90(2):199-202. doi:10.1177/0022034510382548
Gorman A, Kaye EK, Nunn M, Garcia RI. Changes in body weight and adiposity predict periodontitis progression in men. J Dent Res. 2012;91(10):921-926. doi:10.1177/0022034512457372
Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197-206. doi:10.1038/nature14177
Shungin D, Winkler T, Croteau-Chonka DC, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015;518(7538):187-196. doi:10.1038/nature14132
Dong J, Gong Y, Chu T, et al. Mendelian randomization highlights the causal association of obesity with periodontal diseases. J Clin Periodontol. 2022;49(7):662-671. doi:10.1111/jcpe.13640
Zhu Y, Hollis JH. Tooth loss and its association with dietary intake and diet quality in American adults. J Dent. 2014;42(11):1428-1435. doi:10.1016/j.jdent.2014.08.012
Tada A, Miura H. Association of mastication and factors affecting masticatory function with obesity in adults: a systematic review. BMC Oral Health. 2018;18(1):76. doi:10.1186/s12903-018-0525-3
Zhu J, Guo B, Gan X, et al. Association of circulating leptin and adiponectin with periodontitis: a systematic review and meta-analysis. BMC Oral Health. 2017;17(1):104. doi:10.1186/s12903-017-0395-0
Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N, Yoshie H. The effect of periodontal treatment on serum leptin, Interleukin-6, and C-reactive protein. J Periodontol. 2010;81(8):1118-1123. doi:10.1902/jop.2010.090741
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85-97. doi:10.1038/nri2921
Martinez-Herrera M, Silvestre FJ, Silvestre-Rangil J, López-Domènech S, Bañuls C, Rocha M. Levels of serum retinol-binding protein 4 before and after non-surgical periodontal treatment in lean and obese subjects: An interventional study. J Clin Periodontol. 2018;45(3):336-344. doi:10.1111/jcpe.12840
Martinez-Herrera M, López-Domènech S, Silvestre FJ, et al. Dietary therapy and non-surgical periodontal treatment in obese patients with chronic periodontitis. J Clin Periodontol. 2018;45(12):1448-1457. doi:10.1111/jcpe.13030
Mainas G, Santamaria P, Ide M, et al. Could dietary restrictions affect periodontal disease? A systematic review. Clin Oral Investig. 2023;27:4107-4116. doi:10.1007/s00784-023-05052-9
Sales-Peres SH d C, Sales-Peres M d C, Ceneviva R, Bernabé E. Weight loss after bariatric surgery and periodontal changes: a 12-month prospective study. Surg Obes Relat Dis. 2017;13(4):637-642. doi:10.1016/j.soard.2016.08.007
Fontanille I, Boillot A, Rangé H, et al. Bariatric surgery and periodontal status: a systematic review with meta-analysis. Surg Obes Relat Dis. 2018;14(10):1618-1631. doi:10.1016/j.soard.2018.07.017
Ferraz AX, Gonçalves FM, Ferreira-Neto PD, et al. Impact of bariatric surgery on oral health: a systematic review and meta-analysis. Clin Oral Investig. 2023;27(5):1869-1884. doi:10.1007/s00784-023-04959-7
Dale CE, Fatemifar G, Palmer TM, et al. Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization analysis. Circulation. 2017;135(24):2373-2388. doi:10.1161/CIRCULATIONAHA.116.026560
Chan JCN, Malik V, Jia W, et al. Diabetes in Asia epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129-2140.
Lu Y, Hajifathalian K, Ezzati M, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet. 2014;383(9921):970-983. doi:10.1016/S0140-6736(13)61836-X
Gregg EW, Cheng YJ, Narayan KMV, Thompson TJ, Williamson DF. The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004. Prev Med (Baltim). 2007;45(5):348-352. doi:10.1016/j.ypmed.2007.07.020
Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:1-20. doi:10.1186/1471-2458-9-88
Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879-887. doi:10.1001/jama.2020.12567
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly Semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/nejmoa2032183
O'Neil PM, Birkenfeld AL, McGowan B, et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018;392(10148):637-649. doi:10.1016/S0140-6736(18)31773-2
Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous Semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224
Kotin J, Walther C, Wenzel U, et al. Association between periodontitis and metabolic syndrome in the Hamburg City health study. J Periodontol. 2022;93(8):1150-1160. doi:10.1002/JPER.21-0464
Campos JR, Martins CC, Faria SFS, et al. Association between components of metabolic syndrome and periodontitis: a systematic review and meta-analysis. Clin Oral Investig. 2022;26(9):5557-5574. doi:10.1007/s00784-022-04583-x
Pussinen PJ, Kopra E, Pietiäinen M, et al. Periodontitis and cardiometabolic disorders: the role of lipopolysaccharide and endotoxemia. Periodontol 2000. 2022;89(1):19-40. doi:10.1111/prd.12433
Pamuk F, Kantarci A. Inflammation as a link between periodontal disease and obesity. Periodontol 2000. 2022;90(1):186-196. doi:10.1111/prd.12457
Graves DT, Ding Z, Yang Y. The impact of diabetes on periodontal diseases. Periodontol 2000. 2020;82(1):214-224. doi:10.1111/prd.12318
Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021;21(7):426-440. doi:10.1038/s41577-020-00488-6
Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK. Tumor necrosis factor-induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes. 2005;54(10):2939-2945.
Fan HQ, Gu N, Liu F, et al. Prolonged exposure to resistin inhibits glucose uptake in rat skeletal muscles. Acta Pharmacol Sin. 2007;28(3):410-416. doi:10.1111/j.1745-7254.2007.00523.x
Monnier VM, Glomb M, Elgawish A, Sell DR. The mechanism of collagen cross-linking in diabetes a puzzle nearing resolution. Diabetes. 1996;45(Supplement_3):S67-S72.
Lackey DE, Olefsky JM. Regulation of metabolism by the innate immune system. Nat Rev Endocrinol. 2016;12(1):15-20. doi:10.1038/nrendo.2015.189
McMullen JA, Van DTE, Horoszewicz HU, Genco RJ. Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. J Periodontol. 1981;52(4):167-173. doi:10.1902/jop.1981.52.4.167
Manouchehr-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF. Impaired neutrophil chemotaxis in diabetic patients with severe periodontitis. J Dent Res. 1981;60:729-730.
Naguib G, Al-Mashat H, Desta T, Graves DT. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol. 2004;123(1):87-92.
Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: An endocrine organ. Arch Med Sci. 2013;9(2):191-200. doi:10.5114/aoms.2013.33181
Krysiak R, Handzlik-Orlik G, Okopien B. The role of adipokines in connective tissue diseases. Eur J Nutr. 2012;51(5):513-528. doi:10.1007/s00394-012-0370-0
Kumar DP, Koka S, Li C, Rajagopal S. Inflammatory mediators in obesity. Mediators Inflamm. 2019;2019:1-2. doi:10.1155/2019/9481819
Zuza EP, Barroso EM, Carrareto ALV, et al. The role of obesity as a modifying factor in patients undergoing non-surgical periodontal therapy. J Periodontol. 2011;82(5):676-682. doi:10.1902/jop.2010.100545
Zimmermann GS, Bastos MF, Dias Gonçalves TE, Chambrone L, Duarte PM. Local and circulating levels of adipocytokines in obese and normal weight individuals with chronic periodontitis. J Periodontol. 2013;84(5):624-633. doi:10.1902/jop.2012.120254
Medvedev AE, Sabroe I, Hasday JD, Vogel SN. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res. 2006;12(3):133-150. doi:10.1179/096805106X102255
Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Investig. 2017;127(1):1-4. doi:10.1172/JCI92035
Green WD, Beck MA. Obesity altered T cell metabolism and the response to infection. Curr Opin Immunol. 2017;46:1-7. doi:10.1016/j.coi.2017.03.008
Lin H, Duffy JL, Roginshy MS. Micro circulati on diabetes mellitus a study of gingival biopsies. Hum Pathol. 1975;6(1):77-96.
Haffajee AD, Socransky SS. Relation of body mass index, periodontitis and Tannerella forsythia. J Clin Periodontol. 2009;36(2):89-99. doi:10.1111/j.1600-051X.2008.01356.x
Al-Rawi N, Al-Marzooq F. The relation between periodontopathogenic bacterial levels and resistin in the saliva of obese type 2 diabetic patients. J Diabetes Res. 2017;2017:2643079. doi:10.1155/2017/2643079
Blasco-Baque V, Garidou L, Pomié C, et al. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut. 2016;66(5):872-885. doi:10.1136/gutjnl-2015-309897
Erion KA, Corkey BE. Hyperinsulinemia: a cause of obesity? Curr Obes Rep. 2017;6(2):178-186. doi:10.1007/s13679-017-0261-z
Yılmaz G, Kırzıoğlu FY, Doğuç DK, Koçak H, Orhan H. Ghrelin levels in chronic periodontitis patients. Odontology. 2014;102(1):59-67. doi:10.1007/s10266-012-0100-3
Solini A, Suvan J, Santini E, et al. Periodontitis affects glucoregulatory hormones in severely obese individuals. Int J Obes (Lond). 2019;43(5):1125-1129. doi:10.1038/s41366-018-0253-4
Borges T d F, Regalo SC, Taba M, Siéssere S, Mestriner W, Semprini M. Changes in masticatory performance and quality of life in individuals with chronic periodontitis. J Periodontol. 2013;84(3):325-331. doi:10.1902/jop.2012.120069
Kosaka T, Ono T, Kida M, et al. A multifactorial model of masticatory performance: the Suita study. J Oral Rehabil. 2016;43(5):340-347. doi:10.1111/joor.12371
Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177-185. doi:10.1038/nature21363
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-846. doi:10.1038/nature05482
Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380(1-2):24-30. doi:10.1016/j.cca.2007.01.026
Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-298. doi:10.1038/s41574-019-0176-8
Wang Y, Chu T, Gong Y, et al. Mendelian randomization supports the causal role of fasting glucose on periodontitis. Front Endocrinol (Lausanne). 2022;13:13. doi:10.3389/fendo.2022.860274
Shah PD, Schooling CM, Borrell LN. Impact of liability to periodontitis on glycemic control and type II diabetes risk: a Mendelian randomization study. Front Genet. 2021;12:12. doi:10.3389/fgene.2021.767577
Li W, He Y, Zheng Q, Deng X. The causal effect of life course adiposity on periodontitis: a Mendelian randomization study. J Periodontol. 2023;94(2):256-262. doi:10.1002/JPER.21-0632
Cheng L, Zhuang H, Ju H, et al. Exposing the causal effect of body mass index on the risk of type 2 diabetes mellitus: a mandelian randominzation study. Front Genet. 2019;10:94. doi:10.3389/fgene.2019.00094
Emdin CA, Khera AV, Natarajan P, et al. Genetic association of waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and coronary heart disease. JAMA. 2017;317(6):626-634. doi:10.1001/jama.2016.21042
Yuan S, Larsson SC. An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study. Diabetologia. 2020;63(11):2359-2371. doi:10.1007/s00125-020-05253-x
Xu H, Jin C, Guan Q. Causal effects of overall and abdominal obesity on insulin resistance and the risk of type 2 diabetes mellitus: a two-sample Mendelian randomization study. Front Genet. 2020;11:603. doi:10.3389/fgene.2020.00603
Iwasaki M, Borgnakke WS, Ogawa H, et al. Effect of lifestyle on 6-year periodontitis incidence or progression and tooth loss in older adults. J Clin Periodontol. 2018;45(8):896-908. doi:10.1111/jcpe.12920
Faries MD, Abreu A. Medication adherence, when lifestyle is the medicine. Am J Lifestyle Med. 2017;11(5):397-403. doi:10.1177/1559827617697922
Connolly V, Unwin N, Sherriff P, Bilous R, Kelly W. Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. J Epidemiol Community Health. 2000;54(3):173-177. doi:10.1136/jech.54.3.173
Anekwe CV, Jarrell AR, Townsend MJ, Gaudier GI, Hiserodt JM, Stanford FC. Socioeconomics of obesity. Curr Obes Rep. 2020;9(3):272-279. doi:10.1007/s13679-020-00398-7
U.S. Department of Health and Human Services O of DP and HPromotion. Healthy People 2030. Accessed July 26, 2023. Retrieved [date graphic was accessed], from https://health.gov/healthypeople/objectives-and-data/social-determinants-health
Health Diplomacy Why the United Nations General Assembly? https://www.saglikdiplomasisi.org.tr/cms-uploads/2021/06/A-GUIDE-TO-GLOBAL-HEALTH-DIPLOMACY.pdf
Lianov L, Johnson M, Lianov D. Physician competencies for prescribing lifestyle medicine. JAMA. 2010;304:202-203.
Kushner RF, Sorensen KW. Lifestyle medicine: the future of chronic disease management. Curr Opin Endocrinol Diabetes Obes. 2013;20(5):389-395. doi:10.1097/01.med.0000433056.76699.5d
Lawson R. British Society of Lifestyle Medicine: founding principles and current achievements. Am J Lifestyle Med. 2020;14(3):286-288. doi:10.1177/1559827619867627
Pathak N, Pollard KJ, McKinney A. Lifestyle medicine interventions for personal and planetary health: the urgent need for action. Am J Lifestyle Med. 2022;16:589-593. doi:10.1177/15598276221090887
Aggarwal R, Yeh RW, Joynt Maddox KE, Wadhera RK. Cardiovascular risk factor prevalence, treatment, and control in US adults aged 20 to 44 years, 2009 to march 2020. JAMA. 2023;21:899-909. doi:10.1001/jama.2023.2307
Sabbah W, Gomaa N, Gireesh A. Stress, allostatic load, and periodontal diseases. Periodontol 2000. 2018;78(1):154-161. doi:10.1111/prd.12238
KSakki T, Sakki T. Association of lifestyle with periodontal health. Comnnmity Dent Oral Epidemiol. 1995;23:155-163.
Marruganti C, Traversi J, Gaeta C, et al. Adherence to Mediterranean diet, physical activity level and severity of periodontitis. Results from a university-based cross-sectional study. J Periodontol. 2022;93:1218-1232.
Marruganti C, Baima G, Grandini S, et al. Leisure-time and occupational physical activity demonstrate divergent associations with periodontitis: a population-based study. J Clin Periodontol. 2023;50:559-570. doi:10.1111/jcpe.13766
Marruganti C, Romandini M, Gaeta C, et al. Healthy lifestyles are associated with a better response to periodontal therapy: a prospective cohort study. J Clin Periodontol. 2023;50:1089-1100. doi:10.1111/jcpe.13813
Loos BG, Needleman I. Endpoints of active periodontal therapy. J Clin Periodontol. 2020;47:61-71. doi:10.1111/jcpe.13253
M Leite FR, Nascimento GG, Baake S, Pedersen LD, Scheutz F, López R. Impact of smoking cessation on periodontitis: A systematic review and meta-analysis of prospective longitudinal observational and interventional studies. Nicotine Tob Res. 2019;21(12):1600-1608. doi:10.1093/ntr/nty147/5053758
Omori S, Uchida F, Oh S, et al. Exercise habituation is effective for improvement of periodontal disease status: a prospective intervention study. Ther Clin Risk Manag. 2018;14:565-574. doi:10.2147/TCRM.S153397
Sudhanshu A, Sharma U, Vadiraja H, Rana R, Singhal R. Impact of yoga on periodontal disease and stress management. Int J Yoga. 2017;10(3):121. doi:10.4103/0973-6131.213468
Rank F, Nn JOA, Anson EM, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women abstract. N Engl J Med. 2001;345:790-797.
Schlesinger S, Neuenschwander M, Ballon A, Nöthlings U, Barbaresko J. Adherence to healthy lifestyles and incidence of diabetes and mortality among individuals with diabetes: a systematic review and meta-analysis of prospective studies. J Epidemiol Community Health (1978). 2020;74(5):481-487. doi:10.1136/jech-2019-213415
Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. A position statement of the world obesity federation. Obes Rev. 2017;18(7):715-723. doi:10.1111/obr.12551
Butland B, Jebb S, Kopelman P, Mcpherson K. Tackling Obesities: Future Choices-Project Report 2 Nd Edition Government Office for Science Foresight Tackling Obesities: Future Choices-Project Report. www.foresight.gov.uk
Hebebranda J, Albayraka Ö, Adanb R, et al. “Eating addiction”, rather than “food addiction”, better captures addictive-like eating behavior. Neurosci Biobehav Rev. 2014;47:295-306. doi:10.1016/j.neubiorev.2014.08.016
Ramos Salas X, Alberga AS, Cameron E, et al. Addressing weight bias and discrimination: moving beyond raising awareness to creating change. Obes Rev. 2017;18(11):1323-1335. doi:10.1111/obr.12592
Lindstr¨om J, Lindstr¨om L, Louheranta A, Eriksson J, Uusitupa M, Tuomilehto J. The Finnish Diabetes Prevention Study (DPS) Lifestyle Intervention and 3-Year Results on Diet and Physical Activity MARJO MANNELIN, MSC 3 MERJA RASTAS, MSC 4 VIRPI SALMINEN, MSC 5 FOR THE FINNISH DIABETES PREVENTION STUDY GROUP. 2003 http://diabetesjournals.org/care/article-pdf/26/12/3230/590993/dc1203003230.pdf
Aakko J, Uomilehto T, Aana J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350. www.nejm.org
The Diabetes Prevention Program (DPP). 1996 http://www.bsc.gwu.edu/dpp/manuals
Nathan DM, Barrett-Connor E, Crandall JP, et al. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the diabetes prevention program outcomes study. Lancet Diabetes Endocrinol. 2015;3(11):866-875. doi:10.1016/S2213-8587(15)00291-0
Pan X, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537-544.
Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: A 20-year follow-up study. Lancet. 2008;371:1783-1789.
Gong Q, Zhang P, Wang J, et al. Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: a post hoc analysis of Da Qing diabetes prevention outcome study. Diabetes Obes Metab. 2021;23(10):2385-2394. doi:10.1111/dom.14481
Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing diabetes prevention study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014;2(6):474-480. doi:10.1016/S2213-8587(14)70057-9
Johansen MY, Macdonald CS, Hansen KB, et al. Effect of an intensive lifestyle intervention on glycemic control in patients with type 2 diabetes: A randomized clinical trial. JAMA. 2017;318(7):637-646. doi:10.1001/jama.2017.10169
Kelly J, Karlsen M, Steinke G. Type 2 diabetes remission and lifestyle medicine: a position statement from the American College of Lifestyle Medicine. Am J Lifestyle Med. 2020;14(4):406-419. doi:10.1177/1559827620930962
Williamson DA. Fifty years of behavioral/lifestyle interventions for overweight and obesity: where have we been and where are we going? Obesity. 2017;25(11):1867-1875. doi:10.1002/oby.21914
Sotos-Prieto M, Bhupathiraju SN, Falcon LM, Gao X, Tucker KL, Mattei J. Association between a healthy lifestyle score and inflammatory markers among Puerto Rican adults. Nutr Metab Cardiovasc Dis. 2016;26(3):178-184. doi:10.1016/j.numecd.2015.12.004
Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc. 2012;71:298-306. doi:10.1017/S0029665112000158
Wardwell L, Chapman-Novakofski K, Herrel S, Woods J. Nutrient intake and immune function of elderly subjects. J Am Diet Assoc. 2008;108(12):2005-2012. doi:10.1016/j.jada.2008.09.003
Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822-1832. doi:10.1038/s41591-019-0675-0
D'Aiuto F, Nibali L, Parkar M, Patel K, Suvan J, Donos N. Oxidative stress, systemic inflammation, and severe periodontitis. J Dent Res. 2010;89(11):1241-1246. doi:10.1177/0022034510375830
Pink C, Kocher T, Meisel P, et al. Longitudinal effects of systemic inflammation markers on periodontitis. J Clin Periodontol. 2015;42(11):988-997. doi:10.1111/jcpe.12473
Kolb H, Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia. 2010;53(1):10-20. doi:10.1007/s00125-009-1573-7
Garcia C, Feve B, Ferré P, et al. Diabète et inflammation: aspects fondamentaux et implications cliniques. Diabetes Metab. 2010;36(5):327-338. doi:10.1016/j.diabet.2010.07.001
Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822-1832. doi:10.1038/s41591-019-0675-0
Jéquier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci. 2002;967:379-388. doi:10.1111/j.1749-6632.2002.tb04293.x
Dickson SL, Egecioglu E, Landgren S, Skibicka KP, Engel JA, Jerlhag E. The role of the central ghrelin system in reward from food and chemical drugs. Mol Cell Endocrinol. 2011;340(1):80-87. doi:10.1016/j.mce.2011.02.017
Perelló M, Zigman JM. The role of ghrelin in reward-based eating. Biol Psychiatry. 2012;72(5):347-353. doi:10.1016/j.biopsych.2012.02.016
Brydon L, Wright CE, O'Donnell K, Zachary I, Wardle J, Steptoe A. Stress-induced cytokine responses and central adiposity in young women. Int J Obes (Lond). 2008;32(3):443-450. doi:10.1038/sj.ijo.0803767
Torres SJ, Nowson CA. Relationship between stress, eating behavior, and obesity. Nutrition. 2007;23(11-12):887-894. doi:10.1016/j.nut.2007.08.008
Stults-Kolehmainen MA, Sinha R. The effects of stress on physical activity and exercise. Sports Med. 2014;44(1):81-121. doi:10.1007/s40279-013-0090-5
Greenberg BL, Glick M, Tavares M. Addressing obesity in the dental setting: what can be learned from oral health care professionals' efforts to screen for medical conditions. J Public Health Dent. 2017;77:S67-S78. doi:10.1111/jphd.12223
Greenberg BL, Glick M. Assessing systemic disease risk in a dental setting: a public health perspective. Dent Clin N Am. 2012;56(4):863-874. doi:10.1016/j.cden.2012.07.011
Yonel Z, Cerullo E, Kröger AT, Gray LJ. Use of dental practices for the identification of adults with undiagnosed type 2 diabetes mellitus or non-diabetic hyperglycaemia: a systematic review. Diabet Med. 2020;37(9):1443-1453. doi:10.1111/dme.14324
Making Every Contact Count (MECC): Consensus Statement. 2016 www.england.nhs.uk
Sun Y, You W, Almeida F, Estabrooks P, Davy B. The effectiveness and cost of lifestyle interventions including nutrition education for diabetes prevention: a systematic review and meta-analysis. J Acad Nutr Diet. 2017;117(3):404-421.e36. doi:10.1016/j.jand.2016.11.016
Lambrinou E, Hansen TB, Beulens JWJ. Lifestyle factors, self-management and patient empowerment in diabetes care. Eur J Prev Cardiol. 2019;26(2_suppl):55-63. doi:10.1177/2047487319885455
Rodrigues AM, Kemp E, Aquino MRJ, et al. Understanding the implementation of ‘making every contact count’ (MECC) delivered by healthcare professionals in a mental health hospital: protocol for a pragmatic formative process evaluation. Health Psychol Behav Med. 2023;11(1):2174698. doi:10.1080/21642850.2023.2174698
Williamson DA. Fifty years of behavioral/lifestyle interventions for overweight and obesity: where have we been and where are we going? Obesity. 2017;25(11):1867-1875. doi:10.1002/oby.21914
Nathan DM, Barrett-Connor E, Crandall JP, et al. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the diabetes prevention program outcomes study. Lancet Diabetes Endocrinol. 2015;3(11):866-875. doi:10.1016/S2213-8587(15)00291-0
Commissioning Standard: Dental Care for People with Diabetes NHS England and NHS Improvement.